Black patients more likely to be excluded from pancreatic cancer

Disparities in Clinical Research and Cancer Treatment

In an unprecedented move, Huntsman and Fred Hutch add dramatically to their catchment areas in western U.S. - The Cancer Letter

Frontiers Prognostic Factors of Survival in Pancreatic Cancer Metastasis to Liver at Different Ages of Diagnosis: A SEER Population-Based Cohort Study

Dose escalation of radiation therapy with or without induction chemotherapy for unresectable locally advanced pancreatic cancer, Radiation Oncology

Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive review, Insights into Imaging

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704 - Advances in Radiation Oncology

AACI Update

How This Cancer Survivor Is Changing the Game for Black Patients

Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer. - Abstract - Europe PMC

NCI trials for April 2022 - The Cancer Letter

Issue 13 - The Cancer Letter

Frontiers The risk and prognostic factors for G1 pancreatic neuroendocrine tumors: A retrospective analysis of the SEER database

Frontiers Clinical trial-identified inflammatory biomarkers in breast and pancreatic cancers

AACI Update